$97M Series D Backed by Strategic Investors Across the Oncology Ecosystem Positions Thyme Care to Break Through Cancer Care’s Biggest Bottlenecks
Thyme Care achieves profitability, manages more than $5B in oncology spend, and extends access to 8M people nationwide…